Validación de la aplicación móvil TBApp para la gestión del autocuidado de personas con tuberculosis

Assis, Lara Bezerra de Oliveira de; Silva, Denise Maria Guerreiro Vieira da; Silva Junior, Jucimar Maia da; Santos, Edinilza Ribeiro dos; Pinheiro, Jair dos Santos; Sacramento, Daniel Souza; Oliveira, Hermann Jacques Hernani de; Sicsú, Amélia Nunes

Lara Bezerra de Oliveira de Assis Corresponding author: Lara Bezerra de Oliveira de Assis E-mail: larabezerradeassis@gmail.com

conception or design of the study/research

analysis and/or interpretation of data

final review with critical and intellectual participation in the manuscript

Universidade do Estado do Amazonas. Manaus, Amazonas, Brazil

Secretaria Municipal de Saúde de Manaus. Manaus, Amazonas, Brazil

Fundação de Vigilância em Saúde Dra. Rosemary Costa Pinto. Manaus, Amazonas, Brazil

https://orcid.org/0000-0001-9565-7088

Denise Maria Guerreiro Vieira da Silva

analysis and/or interpretation of data

final review with critical and intellectual participation in the manuscript

Universidade do Estado do Amazonas. Manaus, Amazonas, Brazil

https://orcid.org/0000-0003-2139-083X

Jucimar Maia da Silva Junior

analysis and/or interpretation of data

final review with critical and intellectual participation in the manuscript

Universidade do Estado do Amazonas. Manaus, Amazonas, Brazil

https://orcid.org/0009-0003-1382-6100

Edinilza Ribeiro dos Santos

analysis and/or interpretation of data

final review with critical and intellectual participation in the manuscript

Universidade do Estado do Amazonas. Manaus, Amazonas, Brazil

https://orcid.org/0000-0002-3188-0114

Jair dos Santos Pinheiro

final review with critical and intellectual participation in the manuscript

Secretaria Municipal de Saúde de Manaus. Manaus, Amazonas, Brazil

Fundação de Vigilância em Saúde Dra. Rosemary Costa Pinto. Manaus, Amazonas, Brazil

https://orcid.org/0000-0001-6371-5773

Daniel Souza Sacramento

final review with critical and intellectual participation in the manuscript

Secretaria Municipal de Saúde de Manaus. Manaus, Amazonas, Brazil

https://orcid.org/0000-0002-8782-1949

Hermann Jacques Hernani de Oliveira

analysis and/or interpretation of data

final review with critical and intellectual participation in the manuscript

Universidade do Estado do Amazonas. Manaus, Amazonas, Brazil

https://orcid.org/0009-0006-2573-810X

Amélia Nunes Sicsú

conception or design of the study/research

final review with critical and intellectual participation in the manuscript

Universidade do Estado do Amazonas. Manaus, Amazonas, Brazil

https://orcid.org/0000-0001-5217-3710

Corresponding author: Lara Bezerra de Oliveira de Assis E-mail: larabezerradeassis@gmail.com

EDITOR IN CHIEF: Dulce Barbosa

ASSOCIATE EDITOR: Hugo Fernandes

Assessed domains	Item	TD	PD	PA	TA	CVI	Overall CVI
Objective	It is consistent with the needs of people sick with TB	0	0	30%	70%	1	0.96
	It is coherent from the point of view of the process of combating TB	0	0	50%	50%	1
	Promotes change in behavior and attitude	0	10%	60%	30%	0.9
	It can be disseminated in scientific circles in the area of TB	0	0	0%	100%	1
	It meets the objectives of institutions that work with TB	0	10%	30%	60%	0.9
Structure and presentation	The application is adequate for people sick with TB	0	0	50%	50%	1	0.91
	Messages are presented clearly and objectively	0	0	50%	50%	1
	The information presented is scientifically correct	0	0	30%	70%	1
	The application is appropriate to the proposed target audience’s sociocultural level	0	30%	30%	40%	0.7
	The application content has a logical sequence	0	10%	10%	80%	0.9
	The information is well structured in terms of agreement and spelling	0	10%	60%	30%	0.9
	The writing style corresponds to the target audience’s knowledge level	0	10%	50%	40%	0.9
Relevance	Frequently asked questions portray key aspects that should be reinforced	0	0	30%	70%	1	0.92
	The application allows learning about the disease	0	10%	40%	50%	0.9
	The application encourages people suffering from TB to acquire knowledge for their own care	0	10%	30%	60%	0.9
	The application addresses the necessary topics for people suffering from TB	0	10%	30%	60%	0.9
	It is adequate for use by people sick with TB	0	10%	50%	40%	0.9
	The resources available in the application are adequate	0	0	40%	60%	0.9
OVERALL CVI: 0.96 (Domain 1) + 0.91 (Domain 2) + 0.92 (Domain 3) / 3 = 0.93

Assessed domains	Item	Answered received		Final value
Assessed domains	Item	Positive	Negative	SCV	CV
Functionality	The application has the main functions to assist with adherence to TB treatment	9	1	90%	90%
	The application is accurate in performing its functions	8	2	80%
	The application has access security through passwords	10	0	100%
Reliability	The application displays messages when failures occur	9	1	90%	85%
Reliability	The application informs the user of invalid data entry	8	2	80%	85%
Usability	It is easy to understand the concept and application of the software	9	1	90%	83%
	It is easy to learn how to use the app	8	2	80%
	The app offers help clearly	8	2	80%
Efficiency	Software runtime is adequate	8	2	80%	90%
Efficiency	The resources available in the application are adequate	10	0	100%	90%

Item	Subitems
Item	Previous version	Final version
Who are the groups most susceptible to developing tuberculosis?	People living with HIV/AIDS; Persons deprived of liberty; Homeless population; Indigenous; Healthcare professionals; Contacts of tuberculosis patients, mainly children and older adults, and people with diabetes.	People with HIV/AIDS; Inmates; Homeless people; Indigenous; Healthcare professionals; People who live with tuberculosis patients, especially children and the elderly, and people with diabetes.
I started taking the medication, but I felt bad. What should I do?	CONTINUE TO TAKE YOUR MEDICATIONS. It is important that you return to work immediately so that healthcare professionals can assess you.	Return to the healthcare facility immediately so that a healthcare professional can assess you. Do not stop treatment.
Do I need to stop drinking alcoholic beverages during tuberculosis treatment?	YES. You cannot drink alcoholic beverages, such as cachaças, beers, whiskey, wines, and others, during treatment, as there is a risk of complications, such as hepatitis. However, there are patients who are unable to stop drinking, in this case, it is recommended to inform the healthcare professional who is monitoring you and be sure to take your medications.	It is advisable yes. You cannot drink alcoholic beverages, such as cachaças, beers, whiskey, wines, and others, during treatment, as there is a risk of complications, such as hepatitis. However, if you have difficulty stopping drinking or stopping using other drugs, talk to your healthcare professional.
Why is it important to take an HIV test?	Tuberculosis is an infectious disease that is predominant in people living with HIV, due to the compromised immunity of these patients, and is also the main cause of death in this group. Therefore, it is important that you undergo an HIV test due to the relationship between the two diseases.	HIV is a silent disease that compromises the body’s defense against other diseases, such as tuberculosis. When the patient has both diseases (TB and HIV), the chance of worsening is greater. Therefore, early detection through HIV testing is important.
Why do people who live with me have to be tested?	Because the family are generally the people who live with you the most, therefore, they are the ones who are most at risk of becoming infected and falling ill, as they maintained contact before the diagnosis and the start of treatment. It is important that everyone is tested, even if they do not have symptoms, as there is a possibility that their contacts are infected and at risk of developing the disease in the coming years.	Because people who live with you (family) are in the same environment, they are at greater risk of becoming infected and falling ill, because before diagnosis and treatment begins, you release the bacteria that cause the disease into the environment. In this case, it is important that everyone is examined, those with symptoms through sputum examination, and those who do not present symptoms of tuberculosis through the Tuberculin Skin Test (TST) and chest x-ray, as there is a possibility that their contacts are infected and at risk of developing the disease in the coming years.
I am undergoing tuberculosis treatment, what precautions should I take in relation to COVID-19? (question about COVID-19 inserted)	Inserted in the second version.	It is important to maintain treatment and take the following precautions: wearing masks, washing hands with soap and water, using alcohol gel, avoiding crowds, and checking your vaccination schedule against COVID-19. In cases of symptoms such as fever, dry cough, tiredness, sore throat, runny nose, lack of smell and taste, seek the service.

Domains	Positive points	Negative points
1. Objective	Assistance for institutions and healthcare professionals in dealing with TB and difficulties in adhering to treatment.	It accepts the recording of medication intakes, but does not guarantee observation of medication intake.
2. Structure and appearance	Clear and objective texts.	Very technical answers considering the profile of people affected by TB.
3. Relevance	I would recommend it to people who are or are treating people with TB.	Not highlighted.
4. Functionality	The application is an excellent tool to be used during treatment.	Not highlighted.
5. Reliability	Correct information.	Not highlighted.
6. Usability	Using the application is simple, easy to use, with objective and clear information.	The most vulnerable population may not have access to or find it easy to use the tool.
7. Efficiency	Good response time and adequate resources available.	Difficulty recovering the password.

[1] Corresponding author: Lara Bezerra de Oliveira de Assis E-mail: larabezerradeassis@gmail.com

Brasil

Brasil

Validación de la aplicación móvil TBApp para la gestión del autocuidado de personas con tuberculosis

RESUMEN

Objetivos:

Métodos:

Resultados:

Conclusiones: